Post-approval studies (Phase 4)Study completedNCT01107756
What this trial is testing
A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen
Who this might be right for
Neoplasms (no Otherwise Specified)
Sanofi 403